Karpas Strategies’s AbbVie ABBV Stock Holding History

Karpas Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.05M	Hold	6,144	–	–	0.33%	61
2024 Q1	$1.12M	Hold	6,144	–	–	0.35%	59
2023 Q4	$952K	Hold	6,144	–	–	0.31%	62
2023 Q3	$916K	Hold	6,144	–	–	0.34%	62
2023 Q2	$828K	Hold	6,144	–	–	0.28%	68
2023 Q1	$979K	Hold	6,144	–	–	0.35%	58
2022 Q4	$993K	Hold	6,144	–	–	0.35%	57
2022 Q3	$825K	Sell	6,144 -250	-4%	-$35.9K	0.31%	58
2022 Q2	$979K	Hold	6,394	–	–	0.34%	57
2022 Q1	$1.04M	Hold	6,394	–	–	0.33%	59
2021 Q4	$866K	Buy	6,394 +4,019	+169%	+$475K	0.28%	65
2021 Q3	$277K	Hold	2,375	–	–	0.09%	105
2021 Q2	$268K	Sell	2,375 -125	-5%	-$14.1K	0.1%	104
2021 Q1	$271K	Hold	2,500	–	–	0.1%	100
2020 Q4	$268K	Hold	2,500	–	–	0.11%	107
2020 Q3	$219K	Hold	2,500	–	–	0.1%	113
2020 Q2	$245K	Buy	+2,500	New	+$220K	0.12%	104
2020 Q1	–	Sell	-2,500	Closed	-$221K	–	115
2019 Q4	$221K	Buy	+2,500	New	+$208K	0.08%	117
2019 Q2	–	Sell	-2,500	Closed	-$201K	–	123
2019 Q1	$201K	Hold	2,500	–	–	0.08%	119
2018 Q4	$230K	Hold	2,500	–	–	0.11%	105
2018 Q3	$236K	Hold	2,500	–	–	0.1%	107
2018 Q2	$232K	Hold	2,500	–	–	0.1%	107
2018 Q1	$237K	Hold	2,500	–	–	0.1%	107
2017 Q4	$242K	Hold	2,500	–	–	0.1%	108
2017 Q3	$222K	Buy	+2,500	New	+$190K	0.1%	114

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Karpas Strategies's ABBV Position: Q2 2024 in Review

Karpas Strategies held its AbbVie (ABBV) position steady in Q2 2024 at 6,144 shares worth $1.05M. The position accounts for 0.33% of the portfolio, ranked #61.

Karpas Strategies first reported a position in ABBV in Q3 2017 and has held it in 25 quarters since. The position peaked at $1.12M in Q1 2024. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Karpas Strategies held 6,144 shares of AbbVie worth $1.05M as of Q2 2024.
Karpas Strategies left its AbbVie share count unchanged in Q2 2024.
AbbVie made up 0.33% of Karpas Strategies's portfolio in Q2 2024, its #61 holding.
Karpas Strategies first reported a position in AbbVie in Q3 2017 and has held it in 25 quarters since.
Karpas Strategies's AbbVie position peaked at $1.12M in Q1 2024.
3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.